Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Tuesday, 02 December 2025 03:16 PM	Asian-Paints2959.00	Hind-Unilever2474.65	ITC401.30	Trent4231.95	Larsen-and-Toubro4029.70	M-and-M3716.00	Reliance-Industr1548.40	Tata-Motors-PVeh361.95	Tata-Steel167.70	Titan-Company3888.70	SBI969.20	Bharat-Electron413.45	Kotak-Mah-Bank2141.80	Infosys1565.25	Bajaj-Finance1025.65	Sun-PharmaInds1802.95	HDFC-Bank991.30	TCS3133.20	ICICI-Bank1372.15	Power-Grid-Corpn267.50	Maruti-Suzuki16241.00	Axis-Bank1261.15	HCL-Technologies1635.00	NTPC328.70	Bharti-Airtel2108.50	Tech-Mahindra1533.85	Adani-Ports1519.95	UltraTech-Cem11675.50	Bajaj-Finserv2066.15	Eternal-Ltd300.55
15 mins delay SENSEX 85,157.97 [-483.93]	94.30 3.29%	10.85 0.44%	-3.10 -0.77%	13.50 0.32%	-41.40 -1.02%	-24.25 -0.65%	-17.50 -1.12%	-1.80 -0.49%	-0.95 -0.56%	-4.10 -0.11%	-3.95 -0.41%	-3.70 -0.89%	-5.95 -0.28%	2.10 0.13%	5.15 0.50%	-4.90 -0.27%	-11.25 -1.12%	-2.50 -0.08%	-17.75 -1.28%	-2.15 -0.80%	125.00 0.78%	-14.70 -1.15%	-8.20 -0.50%	1.45 0.44%	18.90 0.90%	5.30 0.35%	-10.25 -0.67%	-15.95 -0.14%	-15.40 -0.74%	-0.95 -0.32%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Wockhardt jumps 21% in two days on US FDA nod for Zaynich NDA

02-Dec-25 14:44Hrs IST

The stock has now surged 21.47% over two days, powered by the US FDA's acceptance of its New Drug Application (NDA) for the breakthrough antibiotic Zaynich.

The approval marks a landmark moment as it is the first time an Indian pharmaceutical company has had an NDA for a completely new chemical entity accepted by the US regulator. Zaynich, built on a novel β-lactam enhancer mechanism, has also received Fast Track status for its potential to address urgent medical needs. With over a decade of research behind it, the drug has demonstrated strong efficacy against highly resistant Gram-negative pathogens and has already helped critically ill patients in India and the US through compassionate use. The acceptance reflects confidence in Wockhardt's scientific depth and its global-standard development program.

Wockhardt is a global pharmaceutical and biotechnology company focused on developing innovative anti-infective solutions. The company posted a consolidated net profit of Rs 78 crore in Q2 FY26 compared with a net loss of Rs 22 crore a year earlier, while net sales declined 3.34% YoY to Rs 782 crore.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise